Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01988532 |
Recruitment Status :
Completed
First Posted : November 20, 2013
Last Update Posted : January 18, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Congenital Bleeding Disorder Haemophilia A Haemophilia A With Inhibitors Haemophilia B Haemophilia B With Inhibitors | Other: No treatment given |
Study Type : | Observational |
Actual Enrollment : | 381 participants |
Observational Model: | Cohort |
Time Perspective: | Cross-Sectional |
Official Title: | Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia |
Study Start Date : | October 2013 |
Actual Primary Completion Date : | October 2014 |
Actual Study Completion Date : | October 2014 |

Group/Cohort | Intervention/treatment |
---|---|
Adult PWH |
Other: No treatment given
Subject will only fill out a questionnaire |
- Prevalence of acute (bleed-related) pain (percentage) [ Time Frame: At the first visit (only one study visit) ]
- Prevalence of chronic (arthritic) pain (percentage) [ Time Frame: At the first visit (only one study visit) ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Adult males able to provide consent and complete a survey in English
- Congenital hemophilia A or B with or without inhibitors with any history of joint bleeding or joint pain
- Presentation at the treatment center for a comprehensive annual visit where joint range of motion will be obtained
- Informed consent obtained before any study-related activities. (Study-related activities are any procedure related to recording of data according to the protocol)
Exclusion Criteria:
- Previous participation in this study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01988532
United States, New Jersey | |
Novo Nordisk Investigational Site | |
Plainsboro, New Jersey, United States, 08536 |
Study Director: | Global Clinical Registry (GCR, 1452) | Novo Nordisk A/S |
Publications of Results:
Responsible Party: | Novo Nordisk A/S |
ClinicalTrials.gov Identifier: | NCT01988532 |
Other Study ID Numbers: |
HAEM-4073 U1111-1138-3464 ( Other Identifier: WHO ) |
First Posted: | November 20, 2013 Key Record Dates |
Last Update Posted: | January 18, 2017 |
Last Verified: | January 2017 |
Hemostatic Disorders Hemophilia A Hemophilia B Blood Coagulation Disorders Blood Coagulation Disorders, Inherited Hematologic Diseases |
Coagulation Protein Disorders Hemorrhagic Disorders Genetic Diseases, Inborn Genetic Diseases, X-Linked Vascular Diseases Cardiovascular Diseases |